Confirmatory Study of PRGN-2012 in Patients With RRP

Status:
SUSPENDED

Trial end date:
2029-03-01

Target enrollment:

Participant gender:

The purpose of this confirmatory study is to provide further demonstration of the efficacy of PRGN-2012 for the treatment of RRP in adults.

PHASE3

Precigen, Inc